Article • Digital Pathology
Deep Blue meets Hematoxilin and Eosin
In the nineties Deep Blue, the famous chess computer, defeated Kasparow. Only a year ago Google’s Deepmind managed to master the ancient Chinese Go, known for its utmost complexity.
Diagnostics
Article • Computational pathology
The tipping point for digital pathology
Digital pathology has been the next big thing for about a decade. Yet, today only a few pathology laboratories are fully equipped to digitise their workflow, mainly for legal or financial reasons.
Article • Dutch pathology platform
Augmenting pathology image exchange
A national pathology image exchange platform for The Netherlands is expected to be in place and operational within the next 12 months.
Article • Business facts and figures
The European IVD market
The European Diagnostic Manufacturers Association EDMA (*) presented 2014 market data, and some countries, such as Germany, also provide estimates for 2015, based on Q1 through Q3 2015.
Article • Senology
The core of patient satisfaction & workflow efficiency
Dr Massimo Calabrese, head of the Complex Operative Unit of Diagnostic Senology in Genoa’s San Martino Hospital, examines aspects of stereotactic breast biopsy procedures and workflow and the need for improvements in certain areas of breast diagnostics.
News • Blood gas solutions
Siemens Healthineers to acquire Epocal from Alere
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal Inc. develops and provides point-of-care blood diagnostic systems for healthcare enterprises, including the epoc Blood Analysis System, a handheld, wireless testing solution.
Drug for Parkinson's not likely to cause melanoma
People with the movement disorder Parkinson’s disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds. Yet the results of the study argue against the Parkinson's drug levodopa as the cause.
Sponsored • Fast triage of chest pain patients
ADVIA Centaur High-Sensitivity Troponin I Assay
The ADVIA Centaur® High-Sensitivity Troponin I (TNIH) assay* is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a…
News • Cardiology
Breast implants may impede ECG and lead to false heart attack diagnosis
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).
Article • Algorithms
Pattern recognition: Machines are learning fast
Language recognition on the smartphone, spam filters in the e-mail programme, personalised product recommendations by Amazon or Netflix – all share one feature: they are based on an algorithm that recognises patterns in a set of data. This artificial generation of knowledge is called machine learning.
Article • Professional standards
The role of sonographers: future professionals across Europe?
Ultrasound is often the first line of imaging used in the diagnostic pathway of a patient’s journey into hospital. Additionally, the increased prevalence of chronic conditions and changes in the demographics of the general population has led to an increased demand for ultrasound. Fast-growing advances in technology also shift ultrasound into a more prominent role in patient diagnosis and…
News • Strategic cooperation
SpeeDx and Cepheid announce partnership on European distribution
SpeeDx Pty, Ltd. announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for…
News • Acquisition
Oxford Gene Technology to be acquired by Sysmex Corporation
Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation, a Japanese in vitro diagnostic company.
Interview • Biomarkers
Aiming for the earliest diagnosis of hepatocellular carcinoma
For almost three quarters of hepatocellular carcinoma (HCC) patients in Europe it is too late for curative treatment because the disease is often only diagnosed at a very advanced stage. Interviewed Professor Guido Gerken MD, Director of the Department for Gastroenterology and Hepatology at University Hospital Essen, about improved and timelier diagnostic capabilities that have already been…
News • Diagnostic equpiment
HORIBA Medical launches auto loading hematology system
In order to enhance its hematology portfolio for the small-mid size laboratories segment, HORIBA Medical has developed a new hematology diagnostic solution. The new Yumizen H550 has been designed to meet the challenging laboratories requirements of providing a cost effective solution based on ‘state of art’ hematology diagnosis combined with user friendly operation.
Article • Infection control
Global warming: Science can only react to emerging diseases
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ program for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years. Therefore, key congress topics included the Zika virus, the effects of global warming and the unusually high number of hospital-acquired…
News • Laboratory
Partnership for molecular diagnostic test
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science. The announcement was made at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna to submit its ResistancePlus MG Test for the detection of Mycoplasma genitalium to the US Food & Drug…
Article • Cancer Diagnostics
Liquid biopsies challenge imaging
Novel blood or urine tests can now detect a tumour and but might in future be able to say what type of cancer is developing in which organ.
Article • Genetics
Ascertaining the value of microRNA
European Hospital reports a new approach in molecular diagnostics introduced during the IASLC World Conference in Vienna.
Article • MRI
New technology adapts automatically to individual characteristics
Just in time for the ECR, Siemens Healthineers is coming up with an innovation. Magnetom Vida, the new high-end 3 Tesla MRI scanner with BioMatrix technology from Siemens Healthineers, was launched to the public at University Hospital Tübingen yesterday, where the first system is installed. The new BioMatrix technology adapts automatically to individual anatomical and physiological…
News • Gene Mutation
Researchers identify cause of hereditary skeletal muscle disorder
An international research team from the University Hospital of Munich (LMU), Newcastle University and the University of Liverpool has identified a gene mutation that causes a hereditary skeletal muscle disorder. The study is published in the "American Journal of Human Genetics".
Sponsored • POC-System
Point-of-care ultrasound shows promise for Osgood-Schlatter diagnosis
Dr Ralf Doyscher, from the Department of Sports Medicine at Charité – Universitätsmedizin Berlin, has a close association with soccer at both professional and amateur levels. He recently participated in a scientific project focusing on preventative check-ups for the general health of elite young soccer players, and took the opportunity to simultaneously investigate the potential of…
Article • Innovation
A swift new lab automation system
‘Every single hour, more than 200,000 people worldwide are being diagnosed or treated with our devices,’ Michael Reitermann, COO of Siemens Healthineers, proudly reports. No reason, however, for Siemens to rest on its laurels. Quite the contrary: the company continues to drive innovation.
News • PSP test
Most rapid sepsis point of care diagnostics
Abionic SA announced the receipt of CE Mark (Conformité Européenne) for two novel tests using its easy to use testing platform, abioSCOPE. The CE Mark allows Abionic to commercialize its tests for sepsis risk assessment and management (PSP Test) and iron deficiency throughout the European Union.
News • Investment
Curetis expands its diagnostic platform
Curetis N.V. and the European Investment Bank (EIB) today announced that the EIB granted Curetis a EUR 25 million senior, unsecured loan. The financing is the first growth capital loan under the European Growth Finance Facility (EGFF). It is backed by a guarantee from the European Fund for Strategic Investments (EFSI).